FindTrial
Sign In

Individualised Homoeopathic Medicine in cases of Irritable Bowel Syndrome using Synthesis repertory

Utility of individualised Homoeopathic medicine selected using Synthesis Repertory in cases of Irritable Bowel Syndrome and assessing cases by IBS-SSS - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/073153
Enrollment
40
Registered
2024-08-30
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K58- Irritable bowel syndrome

Interventions

Intervention1: Individualised Homoeopathic Medicine: Individualized Homoeopathic Medicines like Argentum Nitricum, Asafoetida, Nuv Vomica, Podophyllum, China etc. are prescribed on the basis of homoeo

Sponsors

Dr Hemang Panchal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Cases diagnosed as per ROME’s IV Criteria. 2. Patients between 25-50 years of age. 3. Both gender. 4. All Socio-economic Group.

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating women. 2. Patients suffering from other GI disturbances.

Design outcomes

Primary

MeasureTime frame
To study utility of individualized homoeopathic medicine selected using synthesis repertory in cases of Irritable Bowel Syndrome .Timepoint: 15 days—

Secondary

MeasureTime frame
1.To clinically assess treatment outcome in the cases of Irritable bowel syndrome using IBS-SSSTimepoint: 3 months—

Countries

India

Contacts

Public ContactDr Jignesh Patel

Jawaharlal Nehru Homoeopathic Medical College

jhpatel2003@gmail.com9909949221

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026